Antibiotic prophylaxis in cardiac surgery: A prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin

Journal of Antimicrobial Chemotherapy

Volumn 21, Issue 2, 1988, Pages 201-212

  Wilson, A P R ^a   Taylor, B ^a   Treasure, T ^a   Gruneberg R N ^a   Patton, K ^a   Felmingham, D ^a   Sturridge, M F ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; FLUCLOXACILLIN; TEICOPLANIN; TOBRAMYCIN;

BACILLUS SUBTILIS; BONE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HEART SURGERY; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

ANTIBIOTICS; BACTERIAL INFECTIONS; CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; FLOXACILLIN; GLYCOPEPTIDES; HUMAN; SUPPORT, NON-U.S. GOV'T; SURGICAL WOUND INFECTION; TEICOPLANIN; TISSUE DISTRIBUTION; TOBRAMYCIN;

EID: 0023922771     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/21.2.201     Document Type: Article

References (23)

1. Austin, T. W., Coles, J. C., Finley, R. and Schieven, B. (1976). Prophylactic antibiotic therapy and heart valve replacement. Canadian Journal of Surgery 19, 349-52.
2. Burke, J. F. (1961). The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50, 161-8.
3. Daschner, F. D., Eschenbruch, E., Metz, B., Bayer, E. and Schmuziger, M. (1981). Penetration of gentamicin into heart valves, subcutaneous and muscular tissue of patients undergoing open heart surgery. Journal of Cardiovascular Surgery 22, 581-4.
4. Diem, K. and Lentner, C., Eds. (1970). Documenta Geigy. Scientific Tables, 7th edn. Geigy, Basle.
5. Farrington, M., Fenn, A. and Phillips, I. (1985). Flucloxadllin concentration in serum and wound exudate during open heart surgery. Journal of Antimicrobial Chemotherapy 16, 253-9.
6. Farrington, M., Webster, M., Fenn, A. and Phillips, I. (1985). Study of cardiothoradc wound infection at St. Thomas’ Hospital. British Journal of Surgery 72, 759-62.
7. Gardner, M. J. and Altman, D. G. (1986). Confidence intervals rather than P values: estimation rather than hypothesis testing. British Medical Journal 292, 746-50.
8. Goldmann, D. A., Hopkins, C. C., Karchmer, A. W., Abel, R. M., McEnany, M. T., Akins, C. et al. (1977). Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. Journal of Thoracic and Cardiovascular Sttrgery 73, 470-9.
9. Gordon, R. C., Regamey, C. and Kirby, W. M. M. (1972). Serum protein binding of the aminoglycoside antibiotics. Antimicrobial Agents and Chemotherapy 2, 214-6.
10. Hirschmann, J. V. and Inui, T. S. (1980). Antimicrobial prophylaxis: a critique of recent trials. Reviews of Infectious Diseases 2, 1-23.
11. Holley, F. O., Ponganis, K. V. and Stanslri, D. R. (1982). Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clinical Pharmacokinetics 7, 234-51.
12. Maher, E. R., Hollman, A. and Gruneberg, R. N. (1986). Teicoplanin-induced ototoxidty in Down’s syndrome. Lancet 1, 613.
13. Moore-Gillon, J., Eykyn, S. J. and Phillips, I. (1983). Prosthetic valve endocarditis. British Medical Journal 287, 739-41.
14. Penketh, A. R. L., Wansbrough-Jones, M. H., Wright, E., Imrie, F., Pepper, J. R. and Parker, D. J. (1985). Antibiotic prophylaxis for coronary artery bypass graft surgery. Lancet, 1, 1500.
15. Platt, R., Munoz, A., Stella, J., VanDevanter, S. and Koster, J. K., Jr. (1984). Antibiotic prophylaxis for cardiovascular surgery. Efficacy with coronary artery bypass. Annals of Internal Medicine 101, 770-4.
16. Stanbridge, T. N. and Greenall, D. J. B. (1984). Netilmidn prophylaxis in open-heart surgery. Journal of Antimicrobial Chemotherapy 13, Suppl. A, 59-66.
17. Sutherland, R. and Rolinson, G. (1978). Methods of antibiotic assay. Section 2. Penicillins. In Laboratory Methods in Antimicrobial Chemotherapy, (Reeves, D. S., Phillips, I., Williams, J. D. and Wise, R., Eds), pp. 171-8. Churchill Livingstone, Edinburgh.
18. Unsworth, P. F., Heatley, F. W. and Phillips, 1. (1978). Flucloxadllin in bone. Joianal of Clinical Pathology 31, 705-11.
19. Verbist, L., Tjandramaga, B., Hendrickx, B., Van Hecken, A., Van Melle, P., Verbesselt, R. et al. (1984). In vitro activity and human pharmacokinetics of teicoplanin. Antimicrobial Agents and Chemotherapy 26, 881-6.
20. Wilson, A. P. R., O’Hare, M. D., Fehningham, D. and Gruneberg, R. N., (1986a). Teicoplanin- resistant coagulase-negative staphylococcus. Lancet 2, 973.
21. Wilson, A. P. R., Treasure, T., Sturridge, M. F. and Gruneberg, R. N. (19866). Antibiotic prophylaxis in cardiothoradc surgery in the United Kingdom: current practice. Thorax 41, 396-400.
22. Wilson, A. P. R., Treasure, T., Gruneberg, R. N., Sturridge, M. F. and Ross, D. N. (1988). Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxadllin and tobramycin. Journal of Antimicrobial Chemotherapy 21, 213-223
23. Wise, R., Gillett, A. P., Cadge, B., Durham, S. R. and Baker, S. (1980). The influence of protein binding upon tissue fluid levels of six lactam antibiotics. Journal of Infectious Diseases 142, 77-82.